(Q73507054)

English

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies

scientific article published on 01 June 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

based on heuristic

inferred from title

author name string

Yoko Yasuda

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Masanori Isaka

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Tooru Taniguchi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Yanqiu Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Keiko Matano

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Hideyuki Matsui

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Kazunori Morokuma

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Jun-ichi Maeyama

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Kunio Ohkuma

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Norihisa Goto

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Kunio Tochikubo

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

21-22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

2954-2963

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokine responses to recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tetanus antitoxin titration by haemagglutination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of tolerance via the respiratory mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating cellular immune response to oral immunization of humans with cholera toxin B-subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of recombinant cholera toxin B subunit on IL-1beta production by macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900114-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(03)00114-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12798639%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73507054&oldid=2034101206"